BX
Nuveen S&P 500 Buy-Write Income Fund
BXMX · NYSE
$13.26 -2.07% (-$0.28)
Market Cap $1.38B
P/E Ratio 5.97x
Div. Yield 8.22%
ROE -
Bulios Fair Price
$9.78
26.2% downside
Current Price
$13.26
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BXMX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
75 /100
Cheap P/S 60.95x
P/B 0.87x
P/E 5.97x
Growth
4 /100
Declining Book val. growth 2.74%
Rev. growth 9.75%
FCF growth N/A
Profitability
100 /100
Strong Op. margin 39.51%
Net margin 1,018.75%
FCF margin N/A
Quality
75 /100
Excellent Asset turnover 0.01x
ROA 14.31%
ROE N/A
Debt
100 /100
Low Current ratio 1.27x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
31 /100
Unstable Rev. volatility 255.22%
EPS volatility 164.53%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BXMX
Online
Sector
Financial Services
Industry
Asset Management - Income
CEO
Michael Thomas Buckius
Employees
-
Headquarters
Chicago